Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
Research and development expenses	$ 7,924,450	$ 6,099,580
General and administrative expenses	6,962,328	10,981,765
Impairment expense IPRD	0	2,974,000
Lease termination costs	0	979,273
Depreciation	15,608	0
Total operating expenses	14,902,386	21,034,618
Loss from operations	(14,902,386)	(21,034,618)
Other income (expense):
Gain on bargain purchase upon merger	0	13,334,568
Interest income	55,006	353,490
Interest expense	0	(33,559)
Loss before income taxes	(14,847,380)	(7,380,119)
Income taxes (benefit)	0	(381,513)
Net loss	(14,847,380)	(6,998,606)
Comprehensive loss	$ (14,847,380)	$ (6,998,606)
Net loss per share, basic and diluted (in dollars per share)	$ (0.89)	$ (1.44)
Weighted average common shares outstanding basic and diluted (in shares)	16,745,044	4,868,079